menu ☰
menu ˟

Visual acuity remains unchanged after switch to aflibercept treatment

31 Dec 2014
A switch to aflibercept treatment in patients with neovascular age-related macular degeneration resulted in a significant decrease in the number of injections, central retinal thickness and retinal pigment epithelial detachment volume, but visual acu...

Click here to view the full article which appeared in Opthalmology

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.